The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s weight loss drug, Zepbound, for treating moderate-to-severe obstructive sleep apnea (OSA), the most common sleep-related...
Etiket: Diabetes
GLP-1s Beyond Weight Loss and Diabetes: Exploring New Therapeutic Frontiers
The potential health benefits of GLP-1 (glucagon-like peptide-1) drugs, known for their use in weight loss and diabetes management, are expanding. Novo Nordisk recently revealed that...
Eli Lilly’s Zepbound and Mounjaro Now Available in U.S. After Shortages, FDA Says
All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to the latest update...